These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11136992)

  • 21. Diethylmaleate decreased ascorbic acid release induced by cerebral ischemia in cerebral cortex of the anesthetized rat.
    Yang CS; Tsai PJ; Lin NN; Kuo JS
    Chin J Physiol; 2000 Jun; 43(2):49-53. PubMed ID: 10994693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate.
    Phillis JW; Ren J; O'Regan MH
    Brain Res; 2000 Jun; 868(1):105-12. PubMed ID: 10841893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of increased extracellular glutamate levels on the local field potential in the brain of anaesthetized rats.
    Obrenovitch TP; Urenjak J; Zilkha E
    Br J Pharmacol; 1997 Sep; 122(2):372-8. PubMed ID: 9313949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired.
    Sánchez-Carbente MR; Massieu L
    J Neurochem; 1999 Jan; 72(1):129-38. PubMed ID: 9886063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of the uptake and release of neurotransmitter glutamate in cerebral cortical tissue of guinea pigs.
    Takagaki G; Konagaya H
    Neurochem Res; 1985 Aug; 10(8):1059-69. PubMed ID: 2865688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of threo-3-methylglutamic acid with excitatory amino acid transporters in native and recombinant systems.
    Eliasof S; McIlvain HB; Petroski RE; Foster AC; Dunlop J
    J Neurochem; 2001 Apr; 77(2):550-7. PubMed ID: 11299317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylate.
    Esslinger CS; Koch HP; Kavanaugh MP; Philips DP; Chamberlin AR; Thompson CM; Bridges RJ
    Bioorg Med Chem Lett; 1998 Nov; 8(21):3101-6. PubMed ID: 9873684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the glutamate transporter and the sodium-calcium exchanger in the hypoxia-induced increase in intracellular Ca2+ in rat hippocampal slices.
    Yamaguchi S; Endo K; Kitajima T; Ogata H; Hori Y
    Brain Res; 1998 Dec; 813(2):351-8. PubMed ID: 9838190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of glutamate clearance and synaptic efficacy by glial coverage of neurons.
    Oliet SH; Piet R; Poulain DA
    Science; 2001 May; 292(5518):923-6. PubMed ID: 11340204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate uptake impairment and neuronal damage in young and aged rats in vivo.
    Massieu L; Tapia R
    J Neurochem; 1997 Sep; 69(3):1151-60. PubMed ID: 9282938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gliotoxins disrupt alanine metabolism and glutathione production in C6 glioma cells: a 13C NMR spectroscopic study.
    Brennan L; Hewage C; Malthouse JP; McBean GJ
    Neurochem Int; 2004 Dec; 45(8):1155-65. PubMed ID: 15380625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate-dependent glutamine, aspartate and serine release from rat cortical glial cell cultures.
    Rao TS; Lariosa-Willingham KD; Yu N
    Brain Res; 2003 Jul; 978(1-2):213-22. PubMed ID: 12834916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense knockdown of GLAST, a glial glutamate transporter, compromises retinal function.
    Barnett NL; Pow DV
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):585-91. PubMed ID: 10670492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of glutamatergic systems in locus coeruleus to nucleus paragigantocellularis stimulation-evoked behavior.
    Liu N; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 1999 Aug; 63(4):555-67. PubMed ID: 10462184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates.
    Massieu L; Del Río P; Montiel T
    Neuroscience; 2001; 106(4):669-77. PubMed ID: 11682154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ionotropic excitatory amino acid receptor antagonists on glutamate transport and transport-mediated changes in extracellular excitatory amino acids in the rat striatum.
    Bloc A; Samuel D; Forni C; Dusticier N; Kerkerian-Le Goff L
    J Neurochem; 1995 Apr; 64(4):1598-604. PubMed ID: 7891087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of glial glutamate transporter inhibitors on intracellular Na+ in mouse astrocytes.
    Chatton JY; Shimamoto K; Magistretti PJ
    Brain Res; 2001 Mar; 893(1-2):46-52. PubMed ID: 11222991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of theanine, r-glutamylethylamide, on neurotransmitter release and its relationship with glutamic acid neurotransmission.
    Yamada T; Terashima T; Okubo T; Juneja LR; Yokogoshi H
    Nutr Neurosci; 2005 Aug; 8(4):219-26. PubMed ID: 16493792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 13C enrichment of extracellular neurotransmitter glutamate in rat brain--combined mass spectrometry and NMR studies of neurotransmitter turnover and uptake into glia in vivo.
    Kanamori K; Kondrat RW; Ross BD
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):819-36. PubMed ID: 14528919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arachidonic acid inhibits 3H-glutamate uptake with different potencies in rodent central nervous system regions expressing different transporter subtypes.
    Manzoni C; Mennini T
    Pharmacol Res; 1997 Feb; 35(2):149-51. PubMed ID: 9175585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.